TRAIL
From Proteopedia
(Difference between revisions)
Line 7: | Line 7: | ||
</StructureSection> | </StructureSection> | ||
== 3D Structures of TRAIL == | == 3D Structures of TRAIL == | ||
+ | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
[[1d0g]], [[1d4v]], [[1du3]], [[5cir]] - hTRAIL extracellular domain + DR5 extracellular domain - human<br /> | [[1d0g]], [[1d4v]], [[1du3]], [[5cir]] - hTRAIL extracellular domain + DR5 extracellular domain - human<br /> |
Revision as of 09:36, 7 December 2020
|
3D Structures of TRAIL
Updated on 07-December-2020
1d0g, 1d4v, 1du3, 5cir - hTRAIL extracellular domain + DR5 extracellular domain - human
1dg6 – hTRAIL jelly-roll domain
1d2q - hTRAIL extracellular domain
4n90 - hTRAIL extracellular domain + DR5 extracellular domain + antibody
References
- ↑ Daniels RA, Turley H, Kimberley FC, Liu XS, Mongkolsapaya J, Ch'En P, Xu XN, Jin BQ, Pezzella F, Screaton GR. Expression of TRAIL and TRAIL receptors in normal and malignant tissues. Cell Res. 2005 Jun;15(6):430-8. PMID:15987601 doi:http://dx.doi.org/10.1038/sj.cr.7290311
- ↑ Dessein PH, Lopez-Mejias R, Ubilla B, Genre F, Corrales A, Hernandez JL, Ferraz-Amaro I, Tsang L, Pina T, Llorca J, Blanco R, Gonzalez-Juanatey C, Gonzalez-Gay MA. TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis. Clin Exp Rheumatol. 2015 Jul-Aug;33(4):491-7. Epub 2015 May 11. PMID:25962765